TAZICEF Drug Patent Profile
✉ Email this page to a colleague
When do Tazicef patents expire, and when can generic versions of Tazicef launch?
Tazicef is a drug marketed by Hospira and is included in two NDAs.
The generic ingredient in TAZICEF is ceftazidime. There are seventeen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tazicef
A generic version of TAZICEF was approved as ceftazidime by ACS DOBFAR on November 20th, 1985.
Summary for TAZICEF
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 42 |
| Patent Applications: | 6,601 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TAZICEF at DailyMed |
Pharmacology for TAZICEF
| Drug Class | Cephalosporin Antibacterial |
Anatomical Therapeutic Chemical (ATC) Classes for TAZICEF
US Patents and Regulatory Information for TAZICEF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | TAZICEF | ceftazidime | INJECTABLE;INJECTION | 062662-002 | Mar 6, 1986 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Hospira | TAZICEF | ceftazidime | INJECTABLE;INJECTION | 064032-002 | Oct 31, 1993 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Hospira | TAZICEF | ceftazidime | INJECTABLE;INJECTION | 064032-001 | Oct 31, 1993 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Hospira | TAZICEF | ceftazidime | INJECTABLE;INJECTION | 062662-003 | Mar 6, 1986 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Hospira | TAZICEF | ceftazidime | INJECTABLE;INJECTION | 062662-001 | Mar 6, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
